Determinants of membrane association in the SH4 domain of Fyn: Roles of N-terminus myristoylation and side-chain thioacylation  by Rawat, Anoop & Nagaraj, Ramakrishnan
Biochimica et Biophysica Acta 1798 (2010) 1854–1863
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemDeterminants of membrane association in the SH4 domain of Fyn: Roles of
N-terminus myristoylation and side-chain thioacylation
Anoop Rawat, Ramakrishnan Nagaraj ⁎
Centre for Cellular and Molecular Biology, Council of Scientiﬁc and Industrial Research, Uppal Road, Hyderabad 500 007, India⁎ Corresponding author. Tel.: +91 40 27192589; fax:
E-mail address: nraj@ccmb.res.in (R. Nagaraj).
0005-2736/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbamem.2010.06.009a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 May 2009
Received in revised form 13 May 2010
Accepted 10 June 2010





Synthetic peptideThe SH4 domain of Fyn, a member of the Src family of tyrosine kinases, though rich in polar amino acid
residues, anchors to the cytosolic face of membranes upon fatty acylation. In order to probe the requirement
of speciﬁc fatty acylation at the N-terminus and at the side-chain of this domain for membrane-association,
we have studied the interaction of peptides corresponding to the polar segment of the SH4 domain of Fyn
and its mono- and dually fatty acylated analogs with model membranes. While the polar segment without
covalently linked fatty acids (KDKEATKLTEW-amide) does not interact with lipid vesicles, peptides with one
covalently linked fatty acid at the N-terminus or in the side-chain, associate with zwitterionic and anionic
lipids to varying degrees. The interaction of dually acylated peptides (Myr-GK(ε-myr)KDKEATKLTEW-amide
and Myr-GC(S-pal)KDKEATKLTEW-amide) with lipids depends on the linkage between fatty acyl side-chain
and peptide backbone. The peptide chain associates with membranes only when the side-chain acylation is
via an amide bond and not via a thioester bond. Our investigations indicate that acylation is essential for
membrane targeting and unacylated polar stretch of the SH4 domain does not have a role in membrane-
anchoring. Side-chain acylation via a thioester bond not only provides membrane anchorage but also directs
the peptide chain away from the bilayer which might be important to enable the full length protein to
interact with other signaling partners.+91 40 27160591/27160311.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Covalent modiﬁcation of proteins by fatty acids plays a crucial role
in modulating their biological activities and membrane localization
[1–13]. The region of proteins where fatty acylation occurs is variable.
In the Src family of non-receptor protein tyrosine kinases, the
modiﬁcation occurs at the extreme N-terminal region called the
SH4 domain, which is myristoylated at the N-terminal glycine and
palmitoylated at one or more cysteines near the N-terminus [13,14].
In plasma membrane receptors and other membrane proteins,
palmitoylation takes place at one or more cysteines in segments
located at the interface of transmembrane domain and cytoplasmic
tail or within transmembrane domain [2,8]. The fusion protein SNAP-
25 is modiﬁed at cysteine, which occurs in the central region of the
protein [15]. In cysteine string proteins, the domains containing
multiple cysteines are the sites for palmitoylation [16]. Ras proteins
undergo farnesylation at their C-terminus and palmitoylation at
cysteine in the C-terminal region [17]. All trimeric G proteins have
their α-subunit acylated at or near N-terminus with myristate and/or
palmitate [18].Studies on the Src family of protein kinases have provided im-
portant insights into the biochemistry and functions of protein
acylation [19–30]. Src family consists of nine nonreceptor tyrosine
kinases, seven of which are fatty acylated in their N-terminal region
designated as SH4 domain [9,13]. This domain consists of an extreme
N-terminal ‘Met-Gly-Cys’motif followed by a polar region [13]. The N-
terminal glycine has been shown to be an absolute requirement for
myristoylation [28,31]. However, there is no well deﬁned sequence
requirement for palmitoylation other than a cysteine residue [8,19,20].
During biosynthesis, the N-terminal methionine residue is removed by
an aminopeptidase and a myristate is attached to Gly-2 via an amide
bond in a reactionmediated byN-myristoyl transferase [27,32,33]. Cys-
3 is post-translationally modiﬁed by a palmitoyl chain via a thioester
linkage [22,34]. Palmitoylation is enzymatic [35–37]. However, there
are reports that suggest that palmitoylation occurs without the media-
tion of enzymes [38–41]. BothN-terminalmyristoylation and side-chain
palmitoylation are required for targeting the Src family proteins to the
cytosolic face of the membrane [21]. The multiply acylated proteins
segregate into membrane microdomains, rafts or caveolae where these
take part in various signaling processes [22,24,42]. Although two
cysteines are present in the SH4 domain of Fyn, only the Cys proximal to
theN-terminal myristoylated Gly is essential formembrane localization
of Fyn and can also target chimeric proteins to membranes [30,43–45].
Covalently modiﬁed peptides with fatty acids have been good
models to understand how fatty acids modulate binding of the fatty
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suggest that N-terminal acylation with fatty acids could translocate a
polar peptide chain across lipid membranes [51,52]. Examination of
the polar segments of the SH4 domain of the Src family proteins
indicates that the net charge of the polar region is highly variable.
Very little information is available on the localization of the polar
segment of the SH4 domain following the ‘Met-Gly-Cys’ motif in the
membrane. Likewise, apart from the fact that a side-chain thioester
linked palmitate facilitates rapid palmitate turnover which in turn
regulates membrane subdomain targeting of the protein, it is not
knownwhy thioester linkage is preferred over amide linkage for side-
chain acylation. Further, it is unclear why nature has employed
myristate and not palmitate for N-acylation. In order to get an insight
into these various facets of fatty acid acylation, we have studied the
interaction of model peptides spanning the polar region of the SH4
domain of Fyn and its fatty acylated analogs (Table 1) with model
membranes.
2. Materials and methods
2.1. Materials
PAL (5-[4-(9-ﬂuorenylmethyloxycarbonyl) aminomethyl-3,5-
dimethoxy-phenoxy] valeric acid) resin was from Advanced Chemtech
(Louisville, KY, USA). 9-Fluorenylmethoxycarbonyl (Fmoc) protected
amino acids were from Novabiochem AG, Switzerland and Advanced
Chemtech. Coupling reagents used in peptide synthesis were N-
hydroxybenzotriazole hydrate (HOBt) (Advanced Chemtech), 2-(1-H-
benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexa-ﬂuorophosphate
(HBTU) (AdvancedChemtech), andN,N-diisopropylethylamine (Sigma).
Palmitic acid andMyristic acid used for acylation of peptides were from
Sigma-Aldrich, MO, USA. 1-Palmitoyl-2-oleoyl-phosphotidylcholine
(PC), 1-palmitoyl-2-oleoyl-phosphatidylglycerol (PG), cholesterol
(CHL) and sphingomyelin (SM)were fromAvanti Polar lipids, Alabaster,
AL, USA. All reagents and solvents used were of highest purity available.
2.2. Synthesis, acylation and characterization of peptides
All peptides were synthesized on PAL resin using Fmoc chemistry
[53]. Mono fatty acylated peptides were obtained by on-resin
acylation at N-termini or at the side-chains with fatty acids using
the method described elsewhere [54]. In case of side-chain acylated
peptides, N-terminus was acetylated prior to acylation at Cys or Lys
side-chains. Dually acylated peptides were generated by performing
the ﬁrst acylation on-resin at N-termini and then at cysteine −SH
with palmitic acid (Pmpfyn) or at lysine ε-NH2 with myristic acid
(Pmmfyn) using HOBt and HBTU [54]. Removal of 4-methoxytrityl
protecting group on side chains of cysteine and lysine prior to
acylation was carried out by treating with 1.5% triﬂuoroacetic acid
(TFA) in dichloromethane/ethanedithiol, 95:5, v/v (3×2′, 2 ml)
followed by thorough washing ﬁrst with dichloromethane and then
N-methyl pyrrolidone. The complete acylation procedure was carried
out on-resin. The peptide without covalently linked fatty acids,Table 1
Sequences of SH4 domain of Fyn and synthetic peptides.
Peptide Sequencea








a myr and pal denote myristate and palmitate respectively. Ac denotes acetylation.Pfyn, was cleaved and deprotected from the resin by treating with a
mixture containing TFA, phenol, H2O, thioanisole, and ethanedithiol
(16.5:1:1:1:0.5 v/v) for 10–12 h at room temperature. For mono- and
dually acylated peptides, the cleavage mixture contained TFA, m-
cresol, thioanisole and ethanedithiol (10:1:1:0.5 v/v). Unmodiﬁed
peptide was dissolved in deionized water whereas acylated peptides
stockswere prepared in dimethyl sulfoxide. All peptides were puriﬁed
on a Hewlett-Packard 1100 series high-performance liquid chroma-
tography system with Agilent Zorbax 300SB C-18 reversed-phase
column utilizing 0.1% aqueous TFA as mobile phase A and 0.1% TFA in
acetonitrile as mobile phase B. The puriﬁed peptides were character-
ized by matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry on an Applied Biosystem 4800 instrument. All
peptide stocks were quantitated by monitoring the absorbance
of tryptophan at 280 nm in a Lambda35 Spectrophotometer (Perkin
Elmer).Fig. 1. Interaction of unacylated peptide Pfyn with lipid vesicles. (A) Emission spectra
inbuffer (2) and inpresenceof lipid vesicles (2). (B) Changes inﬂuorescence intensity at
emission maximum as a function of lipid concentration in presence of lipid vesicles of
varying composition: PC (■), PC:PG (●), PC:CHL (▲), and PC:SM:CHL (♦). (C) Accessibility
of tryptophan to the aqueous quencher iodide in presence of various lipid vesicles
expressed in terms of NAF. Large unilamellar vesicles were used in all cases.
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For making lipid vesicles of desired compositions, appropriate
lipids dissolved in chloroform/methanol were dried under nitrogen
stream to form lipid ﬁlms. These ﬁlms were further dried in vacuum
for 5 h and then hydrated overnight with 5 mM HEPES buffer (pH
7.4). Small unilamellar vesicles (SUV) were prepared from the
hydrated lipid ﬁlms by vortexing them vigorously followed by
sonication till the suspension became clear. These were subse-
quently centrifuged at 8000 rpm for 5 min to get rid of metal debris.
Large unilamellar vesicles (LUV) were obtained by extruding the
suspension through 200 nm polycarbonate ﬁlter membranes [55].
Homogeneity of the lipid vesicles was veriﬁed by dynamic light
scattering.Fig. 2. Interaction of N-terminal monoacylated peptide Pmfyn with lipid vesicles.
(A) Emission spectra in buffer (2) and in the presence of lipid vesicles (2). (B) Changes
in ﬂuorescence intensity at emission maximum as a function of lipid concentration:
PC (■), PC:PG (●), PC:CHL (▲), and PC:SM:CHL (♦). (C) Accessibility of tryptophan in
peptide to the aqueous quencher iodide expressed in terms of NAF in different lipid
environments as indicated. The asteriskmark (in case of PC-SM-CHL) indicates zero NAF
values. Large unilamellar vesicles were used in all cases.2.4. Steady-state ﬂuorescence measurements
Lipid binding ability of peptides was assessed by monitoring
tryptophan ﬂuorescence in absence and presence of lipid vesicles
with the compositions PC, PC:PG (1:1), PC:CHL (7:3) and PC:SM:CHL
(1:1:1). Tryptophan was excited at 280 nm and emission spectra
recorded between 300–400 nm in a Hitachi F4500 Fluorescence
Spectrometer (Hitachi, Tokyo, Japan) or a Fluorolog 3-22 Fluorescence
Spectrophotometer (Jobin Yvon, USA). The excitation and emission
bandwidths were 2 and 5 nm respectively. All spectra were recorded
in 5 mM HEPES buffer pH 7.4 and peptide concentration was 1–2 μM.
Accessibility of tryptophan in the different peptides to solvent was
assessed by monitoring quenching of tryptophan ﬂuorescence by
iodide in absence and presence of lipid vesicles. Increasing amountsFig. 3. Interaction of N-terminal monoacylated peptide Ppfyn with lipid vesicles.
(A) Changes in ﬂuorescence intensity at emission maximum with increasing lipid
concentration. (B) Changes in the position of emission maximum with increasing lipid
concentration: PC (■), PC:PG (●), PC:CHL (▲), and PC:SM:CHL (♦). (C) Exposure of
tryptophan residue in the peptide to the aqueous quencher iodide in presence of
various lipid vesicles. Asterisk marks in the panel indicate zero NAF values. LUV were
used in all cases.
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ﬁxed peptide concentration of 1–2 μM. The data for ﬂuorescence
quenching were analyzed by Stern–Volmer plots using the equation
F0/F=1+Ksv[Q], where F0 and F are the ﬂuorescence intensities of
Trp in absence and presence of quencher respectively at quencher
concentration [Q], and Ksv is the Stern–Volmer quenching constant.
The normalized accessibility factor (NAF) was calculated from the
ratios of Ksv obtained from the quenching of Trp ﬂuorescence in the
presence and absence of liposomes.
2.5. Surface activity measurements
Surface activity of the unacylated and acylated peptides was
evaluated by spreading them on air–water interface in a Langmuir–
Blodgett Trough (NIMA Technology, Coventry, UK). Peptidemonolayers
were prepared by spreading increasing amounts of peptides over
the surface of HEPES buffer (5 mM, pH 7.4) at room temperature. These
monolayers were then symmetrically compressed at a constant speed
of 30 cm2/minandpressure-area isotherms recorded in termsof change
in surface pressure vs. surface area with the help of NIMA software
provided with the system.
3. Results
3.1. Synthesis of mono- and dually acylated peptides
The ‘Met-Gly-Cys’ motif at the extreme N-terminus of the SH4
domain of Src family kinases serves as a recognition motif for
myristoylation and palmitoylation rather than having a structural role
[9–13]. Although two Cys residues are present in the SH4 domain,
majority of the protein is fatty acylated at the N-terminal Gly and Cys
at the second position [24]. Hence, the presence of triple fatty
acylation is not necessary for the membrane binding of Fyn. The
sequences of synthetic peptides spanning the SH4 domain of Fyn are
shown in Table 1. Peptide Pfyn spans the polar segment of Fyn
adjacent to the acylation sites. Pmfyn and Ppfyn are peptides fatty
acylated at the N-terminal Lys. Pamfyn and Papfyn are peptides fattyFig. 4. Interaction of N-terminal myristoylated peptide Pmfyn with SUV composed of PC:CH
(2, in the presence of SUV). (B,D) Changes in ﬂuorescence intensity at emission maximumacylated at the side-chains. The dually fatty acylated peptide Pmmfyn
has a myristic acid at the N-terminus and also at the side chain of Lys
by an amide bond. Peptide Pmpfyn is modiﬁed at the cysteine with
palmitic acid and has a myristoyl chain at the N-terminus. Myristate
was chosen to acylate Pmmfyn at the side-chain rather than palmitate
as lysine side-chain itself would contribute three additional –CH2–
moieties as compared to Cys. We chose a coded amino acid rather
than L-2,3 diamino propionic acid, which would have been a more
appropriate cysteine analog for comparison with Pmpfyn.
3.2. Interaction of peptides with model membranes
The emission spectra of the peptides in the presence of SUV and
LUV with varying lipid composition were examined at a ﬁxed
concentration of peptide. Lipid compositions were selected so as to
mimic the mammalian cell membrane and membrane rafts that are
rich in cholesterol and sphingomyelin [56–58]. The interaction of
peptides with lipid vesicles with varying lipid composition was
determined by titrating a ﬁxed concentration of peptide with lipid
vesicles of varying composition. Fluorescence spectra shown are at
lipid–peptide ratios wheremaximal changes are observed. Location of
Trp was examined by quenching observed on titration with KI. Data
are presented as normalized accessibility factor (NAF) calculated as
described in Materials and methods.
Fluorescence data for interaction of Pfyn with LUV are shown in
Fig. 1. The ﬂuorescence spectra indicate very small changes in the
position of emission maximum (λmax). Quenching of ﬂuorescence is
observed which is dependent on the lipid composition. While small
changes are observed with PC and PC:PG vesicles, discernible
quenching is observed with PC containing CHL and SM. The NAF
values indicate that Trp is accessible to I−. A small extent of protection
is observedwith PC, PC:CHL and PC:SM:CHL. Very similar ﬂuorescence
changes were observed with SUV (data not shown).
Fluorescence spectra of Pmfyn and variations in intensity in the
presence of LUV as a function of lipid concentration are shown in Fig. 2.
While no blue shift in λmax is observed, quenching of ﬂuorescence is
observed with all the lipid compositions. Relatively greater quenchingL (Panels A and B) and PC:PG (Panels C and D). (A,C) Trp emission spectra, (2, buffer),
in the presence of SUV as a function of lipid concentration.
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−was probed, considerable protection was observed with all the lipid
vesicles as compared to Pfyn. The changes in λmax and ﬂuorescence
intensity (If) for Ppfyn in the presence of LUV are shown in Fig. 3.
Changes in the position of λmax were not discernible except for 4 nm
blue shift in the presence of PC:PG vesicles. Unlike in the case of Pmfyn,
the decrease in ﬂuorescence intensity was not substantial in the
presence of PC:-PG vesicles. Decrease in If wasmorewhen CHL and SM
were present in PC as compared to PC alone. The NAF values indicate
less accessibility to I− as compared to Pmfyn indicating that despite
the absence of substantial blue shift, the Trp residue is not accessible to
aqueous quenchers.
The spectra of Pmfyn in the presence of SUV composed of PC-CHL
and PC:PG vesicles are shown in Fig. 4. Blue shift in λmax is observed in
the presence of PC:PG vesicles. The maximum change is observed
when the lipid–peptide ratio is ∼20:1. Changes If in the presence of
PC:CHL and PC-PG vesicles are different. While there is considerable
quenching of ﬂuorescence with PC:CHL vesicles, enhancement in If is
observed after initial quenching. However, the NAF values indicate
inaccessibility of Trp to I− as in the case of LUV (data not shown).
The ﬂuorescence spectra data for Ppfyn in the presence of SUV are
shown in Fig. 5. Blue shift in the λmax is observed with PC:CHL and PC-
PG vesicles. If decreases initially and then increases with PC:CHL
vesicles whereas increase is observed with PC:PG vesicles. TheFig. 5. Interaction of N-terminal palmitoylated peptide Ppfyn with SUV. PC:CHL (Panels A, C, a
presence of SUV). (C,D) Changes in the position of ﬂuorescence emission maximum as a f
maximum as a function of lipid concentration.maximum blue shift is observed at a lipid–peptide ratio of 20:1
whereas increase in If is observed over a range of lipid concentration.
The changes in blue shift are more gradual with PC:CHL vesicles. In
spite of these variations, the NAF values indicate the Trp is totally
inaccessible to I− (data not shown).
The ﬂuorescence spectral data for Pamfyn and Papfyn are shown in
Fig. 6. Quenching of ﬂuorescence with very little blue shift in λmax is
observed. The data is similar to Pmfyn. In the case of Papfyn, small
blue shift is observedwith PC and PC:PG vesicles but not with CHL and
SM containing vesicles. Decrease in If is considerable with PC:SM:CHL
and PC:CHL (7:3) but not with PC and PC:PG vesicles. Notwithstand-
ing changes in If and λmax, Trp is not accessible to I− in the presence of
all the lipid vesicles.
The effect of dual acylation at the N-terminus and side chain on
membrane-association in context of the nature of the linkage
connecting acyl side-chain to the peptide backbone was examined.
The two peptides investigated had the fatty acid linked to the peptide
via amide and thioester bonds. They are Pmmfyn and Pmpfyn
respectively. Fluorescence spectra of Pmpfyn in the presence of lipid
vesicles are shown in Fig. 7. The changes in ﬂuorescence properties
are small. The NAF data indicate that the Trp residue is accessible to I−
as compared to the mono acylated peptides except in the presence of
PC vesicles. The ﬂuorescence data for Pmmfyn presented in Fig. 8
shows changes in If and λmax with increasing lipid concentration.nd E) and PC:PG (Panels B, D, and F). (A) Trp emission spectra, (2, buffer) and (2, in the
unction of lipid concentration. (E,F) Changes in the ﬂuorescence intensity at emission
Fig. 6. Interactions of side-chain monoacylated peptides Pamfyn (Panels A, C, and E) and Papfyn (Panels B, D, and F) with LUV. (A,B) Variation of ﬂuorescence intensity at emission
maximum with increasing lipid concentration. (C,D) Variation in the position of emission maximum as a function of increasing lipid concentration. PC (■), PC:PG (●), PC:CHL (▲),
and PC:SM:CHL. (♦). (E,F) Protection offered by these vesicles to Trp in Pamfyn and Papfyn respectively, against aqueous quencher iodide expressed in terms of NAF. Asterisk marks
indicate zero NAF values.
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PC:SM:CHL LUV, the NAF values are very small with all the four LUV
indicating that Trp is associated with the lipid vesicles.
The aggregation behavior of the peptides was examined by
recording 90° scatter as a function of time. No increase in scatter
was observed for mono acylated peptides. Increase in scatter was
observed for Pmmfyn and Pmpfyn suggesting aggregation in aqueous
medium (Fig. 9). However, the Trp residue was accessible to
quenching by I− in both the peptides suggesting that aggregation
does not prevent interaction with lipid vesicles.
3.3. Surface activity of peptides
Surface activity of the peptides was determined by examining
pressure-area isotherms when the peptides were layered on to air–
water interface at different peptide concentrations in a Langmuir–
Blodgett apparatus. The isotherms for the surface-active peptides at
maximum peptide concentrations used are shown in Fig. 10. Pfyn
was not surface active (data not shown). Fatty acylation clearly
renders the peptides surface-active. The pressure-area isotherms
suggest that orientation of the peptides at the air–water interface
depends on the number of fatty acyl chains. The ﬁrst pressure increase
for the peptides occurs at molecular areas N100 Å2. A collapsepressure ∼22 mN/m is observed for Pmfyn but not for the other
peptides. The lift-off value (indicated by arrow mark in Fig. 10) is
greater for Pmmfyn followed by values for Pmfyn, Ppfyn and Pmpfyn.
4. Discussion
We have investigated the interaction of synthetic unacylated,
mono- and di-acylated peptides spanning the polar SH4 domain of
Fyn with model membranes. In an attempt to determine why side-
chain thioester linkage is preferred over amide linkage, dually
acylated peptides Pmmfyn and Pmpfyn were generated containing
N-myristoyl-glycyl-(ε-myristoyl)-lysyl and N-myristoyl-glycyl-(S-
palmitoyl)-cysteinyl moieties respectively, at the N-terminal of the
polar segment of the SH4 domain of Fyn. Myristate was chosen to
acylate Pmmfyn at the side-chain rather than palmitate as lysine side-
chain itself would contribute three additional—CH2—moieties.
Pmmfyn and Pmpfyn both contain N-myristoylated glycine since it
is an absolute requirement for side-chain acylation in vivo [28,31].
From ﬂuorescence measurements, it is evident that the unacylated
peptide Pfyn associates weakly with lipid bilayers which could be
the reason why Fyn associates to some extent with membranes
[43,46]. N-terminal acylation with myristic or palmitic acid results
in association of peptide with lipid bilayer to varying degrees. N-
Fig. 7. Fluorescence properties of Pmpfyn in buffer and LUV. (A) Fluorescence emission
spectra of dually acylated peptide Pmpfyn in buffer and in the presence of LUV. Buffer
(dash dot dot), PC (dot), PC:PG (dash), PC:CHL, (dash dot) and PC:SM:CHL (continuous
line). (B) Exposure of Trp to the aqueous quencher iodide in lipid vesicles expressed as
NAF. Asterisk mark indicates zero NAF value.
Fig. 8. Fluorescence properties of Pmmfyn. (A) Changes in ﬂuorescence intensity.
(B) Changes in the position of emission maximum as a function of increasing lipid
concentration in presence of various LUV: PC (■), PC:PG (●), PC:CHL (▲), and PC:SM:
CHL (♦).
Fig. 9. Aggregation behavior monitored by recording 90° scatter as a function of time.
(A) Pmfyn. (B) Pmmfyn and (C) Pmpfyn. Peptide concentrations: 1, buffer; 2, 1 μM;
3, 2 μM.
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lipid bilayer as compared to myristoylation. The N-palmitoylated
peptide Ppfyn strongly binds to the lipid bilayer irrespective of the
vesicle composition. N-terminal fatty acylation clearly has the ability
to “force” the charged region of the peptide to be associated with the
polar head-group region of the lipid bilayer. In nature, N-terminal
acylation is always at the glycine residue. However, this may be
related to the biosynthetic process of acylation. Our results show that
the N-terminal ‘Met-Gly-Cys’ motif is not essential for membrane
anchorage of the SH4 domain of Fyn and it is the N-terminal acyl chain
which is required for membrane association.
Peitzch and McLaughlin [59] have determined the unitary Gibbs
free energy (ΔGuo) of myristoylated di and tri peptides. Based on the
ΔGuo values, they have concluded that myristoylation would not
provide a strong membrane anchor. They have suggested that lower
hydrophobicity of myristate as compared to palmitate would favor
reversible association of myristoylated protein with membranes.
They have further suggested that partitioning ofmyristoylated protein
into membranes could be dependent on several factors. Our study
indicates that N-terminal mono acylation results in the peptide
chain being associated with the lipid bilayer irrespective of the lipid
composition. Absence of large blue shift in the λmax in the fatty
acylated peptides indicates interfacial localization for Trp. The peptide
chain is associated peripherallywith the bilayer. Since the Trp residues
Fig. 10. Surface activity of mono and dually acylated peptides shown as pressure-area isotherms. (A) Pmfyn. (B) Ppfyn. (C) Pmmfyn and (D) Pmpfyn. Arrowmark indicates the take-
off surface-area in each case.
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the case of Pmpfyn, it is evident that the peptide chain is “forced” into
peripheral association with the lipid bilayer. Changes in ﬂuorescence
parameters for the mono acylated peptides suggest a preference for
CHL and SM containing PC vesicles. The side-chain monoacylated
peptides exhibit similar lipid binding behavior as N-terminal acylated
peptides. The peptide chain is unlikely to be buried in the lipid bilayer
as cationic residues would prevent it. However, it is also unlikely that
the peptide chain loops out and only the Trp residue is associatedwith
the bilayer. Exclusion of the peptide chain from the bilayer is only
observed for Pfyn and Pmpfyn. Side-chain acylation via a thioesterFig. 11. A model for the association of acylated peptides derived from the polar segment of
palmitoylated). (C) Dually acylated Pmmfyn where side chain acylation is via amide bond an
represent lipid headgroups. Thin zigzag lines depict acyl chains ofmembrane phospholipids. Th
peptides. N represents amide bond, S represents thioester bond and Trp stands for tryptophanbond rather than an amide bond appears to “extrude” the peptide
chain from the bilayer. This is observed only with the dually acylated
peptides and not with mono acylated peptides either at the N-termini
or in the side-chain.
Since there is no consensus sequence in the SH4 domains, multiple
acylation via N-terminus and side-chain could serve to prevent the
peptide chain of the SH4 domain associate with the bilayer and
thereby facilitate interaction of the kinases with components of the
signaling pathway. In nature, side-chain acylation is almost always via
a thioester linkage [1–3]. Thioester bonds are labile as compared to
amide bonds and palmitoylation is a dynamic process that would bethe SH4 domain of Fyn with lipid bilayer. (A) Pmfyn (N-myristoylated). (B) Ppfyn (N-
d (D) dually acylated Pmpfyn where side-chain acylation is via a thioester bond. Circles
ick zigzag lines representmyristoyl (markedm) and palmitoyl (marked p) chains linked to
residue. The peptide chain is shown by a thick curved line in the head group region.
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data indicate that side-chain acylation via an amide bond favors
association of the peptide chain with lipid bilayer interfacial region as
compared to side-chain acylation via a thioester bond as with Pmpfyn.
The surface-area isotherms for mono and dually acylated peptides
indicate that not only does acylation renders the hydrophilic sequence
surface active but also results in differential orientations of peptide
chain with respect to acyl chain. The larger compression areas for
Pmfyn as compared to Ppfyn suggest differences in orientation of the
fatty acyl chains and peptides at the interface. Similar observations for
Pmmfyn as compared to Pmpfyn suggest differences in the orientation
of the peptide chain with respect to the fatty acyl chains in the dually
fatty acylated peptides too. The data suggest that the peptide chain is
oriented on the interface when the fatty acyl chains are myristoyl.
Whenmyristoyl and palmitoyl chains are present, the peptide chain is
oriented in the aqueous phase below the interface. Whereas in the
dually acylated peptides, the resistance to compression is largely due
to fatty acyl chains.
Based on the present study, a model for association of acylated
peptides with lipid bilayer can be proposed which is depicted in
Fig. 11. N-myristoylation (and monoacylation via side-chain) results
in association of the peptide chain with the bilayer surface. N-
palmitoylation results in deeper insertion into the interfacial region.
Orientation of dually acylated peptides in the lipid bilayer depends on
the nature of fatty acylation, particularly with reference to the nature
of the bond linking the fatty acid to the side-chain. When the
attachment is via an amide bond as in Pmmfyn, both the acyl chains
insert into the lipid bilayer and the peptide chain is oriented on the
bilayer surface in a manner that forces the Trp residue below the
interfacial region. In Pmpfyn where the fatty acid is linked to Cys via
a thioester bond, the peptide chain does not insert into the bilayer
with Trp exposed to the aqueous environment. Probably this is why
side-chain acylation in nature is almost always thioester linked.
However, side-chain mono acylation via a thioester bond clearly
results in the peptide chain being associated with the bilayer surface.
We have observed quenching of Trp ﬂuorescence in the presence of
lipid vesicles. It is conceivable that the quenching is due to the
phosphate groups from the phospholipids. Similar observations have
been reported earlier [60,61]. The observed quenching of ﬂuorescence
is consistent with the model presented in Fig. 11. Thus, apart from
being a labile bond favoring palmitoylation–depalmitoylation, our
investigations suggest that N-terminal myristoylation and side-chain
fatty acylation via a thioester bond provides a stable membrane
anchor and facilitates positioning of the peptide chain away from the
bilayer particularly with cholesterol and sphingomyelin containing
lipid vesicles and unlike in the case when side-chain fatty acylation is
via an amide bond in Pmmfyn. This would enable the full length
protein to interact with other signaling partners. Our results provide a
rationale for N-terminal myristoylation and side-chain fatty acylation
via a thioester bond.Acknowledgements
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